• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5076362)   Today's Articles (69)
For: Unger J. Rationale use of GLP-1 receptor agonists in patients with type 1 diabetes. Curr Diab Rep 2013;13:663-8. [PMID: 23955813 DOI: 10.1007/s11892-013-0404-x] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Number Cited by Other Article(s)
1
Wu SL, Wang T, Li XY, Gongpan P, Huang XY, Ma YB, Geng CA. Antidiabetic constituents of Kaempferiae rhizoma: Previously undescribed O-linked diarylheptanoid dimers promoting GLP-1 secretion via PKA-CREB pathway. PHYTOCHEMISTRY 2025;236:114496. [PMID: 40180008 DOI: 10.1016/j.phytochem.2025.114496] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2024] [Revised: 03/26/2025] [Accepted: 03/29/2025] [Indexed: 04/05/2025]
2
Furió-Novejarque C, Díez JL, Bondia J. GLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review. J Diabetes Sci Technol 2025;19:332-339. [PMID: 39411979 PMCID: PMC11571630 DOI: 10.1177/19322968241285925] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2024]
3
Zhang J, Ma Y, Zu Q, Wang X, Zhang Y. GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report. Medicine (Baltimore) 2024;103:e39799. [PMID: 39331877 PMCID: PMC11441871 DOI: 10.1097/md.0000000000039799] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/23/2024] [Accepted: 09/02/2024] [Indexed: 09/29/2024]  Open
4
Delrue C, Speeckaert MM. Mechanistic Pathways and Clinical Implications of GLP-1 Receptor Agonists in Type 1 Diabetes Management. Int J Mol Sci 2024;25:9351. [PMID: 39273299 PMCID: PMC11395482 DOI: 10.3390/ijms25179351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2024] [Revised: 08/25/2024] [Accepted: 08/27/2024] [Indexed: 09/15/2024]  Open
5
Kapellen TM. Pharmacotherapy of Children and Adolescents with Type 1 Diabetes Mellitus. Handb Exp Pharmacol 2020;261:105-118. [PMID: 31342276 DOI: 10.1007/164_2019_245] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
6
Tosur M, Redondo MJ, Lyons SK. Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes. Curr Diab Rep 2018;18:79. [PMID: 30116997 DOI: 10.1007/s11892-018-1041-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
7
Trautmann ME, Vora J. Use of glucagon-like peptide-1 receptor agonists among individuals on basal insulin requiring treatment intensification. Diabet Med 2018;35:694-706. [PMID: 29478255 PMCID: PMC5969085 DOI: 10.1111/dme.13610] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 02/21/2018] [Indexed: 12/14/2022]
8
Harris K, Boland C, Meade L, Battise D. Adjunctive therapy for glucose control in patients with type 1 diabetes. Diabetes Metab Syndr Obes 2018;11:159-173. [PMID: 29731652 PMCID: PMC5927142 DOI: 10.2147/dmso.s141700] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]  Open
9
Mader JK, Jensen L, Ingwersen SH, Christiansen E, Heller S, Pieber TR. Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus. Clin Pharmacokinet 2017;55:1457-1463. [PMID: 27282158 PMCID: PMC5069309 DOI: 10.1007/s40262-016-0413-4] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
10
Pafili K, Maltezos E, Papanas N. Dapagliflozin for the treatment of type 1 diabetes mellitus. Expert Opin Investig Drugs 2017;26:873-881. [DOI: 10.1080/13543784.2017.1339788] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
11
Minges KE, Whittemore R, Chao AM, Jefferson V, Murphy KM, Grey M. Clinical, Psychosocial, and Demographic Factors Are Associated With Overweight and Obesity in Early Adolescent Girls With Type 1 Diabetes. DIABETES EDUCATOR 2016;42:538-48. [PMID: 27302183 DOI: 10.1177/0145721716654006] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
12
Silko IV, Nikonova TV, Shestakova MV. Incretins role in Latent autoimmune diabetes of adults pathogenesis, the possibility of therapy with combination of glucagon-like peptide-1 agonist (GLP-1) and insulin. OBESITY AND METABOLISM 2016. [DOI: 10.14341/omet201623-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
13
Zanotto C, Simão F, Gasparin MS, Biasibetti R, Tortorelli LS, Nardin P, Gonçalves CA. Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats. Mol Neurobiol 2016;54:2154-2166. [PMID: 26927659 DOI: 10.1007/s12035-016-9798-1] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2015] [Accepted: 02/16/2016] [Indexed: 01/08/2023]
14
Lee CY. Glucagon-Like Peptide-1 Formulation--the Present and Future Development in Diabetes Treatment. Basic Clin Pharmacol Toxicol 2015;118:173-80. [PMID: 26551045 DOI: 10.1111/bcpt.12524] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2015] [Accepted: 10/29/2015] [Indexed: 12/17/2022]
15
Irwin N, Pathak V, Pathak NM, Gault VA, Flatt PR. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes. Diabetes Obes Metab 2015;17:887-95. [PMID: 26095087 DOI: 10.1111/dom.12508] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 05/26/2015] [Accepted: 06/05/2015] [Indexed: 01/11/2023]
16
Gallwitz B. GLP-1 Receptor Agonists in Type 2 Diabetes and Beyond - New Insights 2015. EUROPEAN ENDOCRINOLOGY 2015;11:21-25. [PMID: 29632562 PMCID: PMC5819057 DOI: 10.17925/ee.2015.11.01.21] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/26/2015] [Accepted: 03/17/2015] [Indexed: 12/21/2022]
17
Moffett RC, Patterson S, Irwin N, Flatt PR. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes. Diabetes Metab Res Rev 2015;31:248-55. [PMID: 25256010 DOI: 10.1002/dmrr.2608] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/09/2014] [Accepted: 09/11/2014] [Indexed: 12/20/2022]
18
Vasu S, Moffett RC, McClenaghan NH, Flatt PR. Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cells. J Mol Endocrinol 2015;54:91-104. [PMID: 25527608 DOI: 10.1530/jme-14-0214] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
19
Scarlett JM, Schwartz MW. Gut-brain mechanisms controlling glucose homeostasis. F1000PRIME REPORTS 2015;7:12. [PMID: 25705395 PMCID: PMC4311273 DOI: 10.12703/p7-12] [Citation(s) in RCA: 30] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Grants] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
20
Du Q, Wang YJ, Yang S, Han P. Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients. Patient Prefer Adherence 2015;9:281-7. [PMID: 25709414 PMCID: PMC4332288 DOI: 10.2147/ppa.s64691] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]  Open
21
Bloch O, Broide E, Ben-Yehudah G, Cantrell D, Shirin H, Rapoport MJ. Nutrient induced type 2 and chemical induced type 1 experimental diabetes differently modulate gastric GLP-1 receptor expression. J Diabetes Res 2015;2015:561353. [PMID: 25893200 PMCID: PMC4393893 DOI: 10.1155/2015/561353] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/04/2015] [Revised: 02/24/2015] [Accepted: 03/03/2015] [Indexed: 01/09/2023]  Open
22
Trujillo JM, Nuffer W. GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents. Pharmacotherapy 2014;34:1174-86. [DOI: 10.1002/phar.1507] [Citation(s) in RCA: 64] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
23
Scholz GH, Fleischmann H. Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making. Ther Adv Endocrinol Metab 2014;5:95-123. [PMID: 25419451 PMCID: PMC4236299 DOI: 10.1177/2042018814556099] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]  Open
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA